SHANGHAI, Aug. 4, 2025 /PRNewswire/ — Aphranel, China’s leading innovator of regenerative aesthetics medicine, recently made waves at IMCAS China 2025 with its 36㎡ platinum sponsorship booth, hosted a 60-minute scientific symposium and 30-minute live-case with its breakthrough product Aphranel® MagiCCrystal CaHA Filler.
IMCAS leadership including Congress Chair Prof. Cui Haiyan, IMCAS Paris Chairmen Dr. Cartier and Dr. Garson visited Aphranel, recognizing its significant contributions to global industry of regenerative aesthetics medicine. This high-profile exhibiting in IMCAS China, demonstrated the Aphranel’s growing influence on the advanced anti-aging solutions in the global market.
About Aphranel
Aphranel® is a high-profile medical aesthetics brand under Shanghai MOYOM Biotechnology, dedicated to advancing global aesthetics technology through cutting-edge biomaterial innovation.
ข่าวที่เกี่ยวข้อง
- Malaysia Airlines Maintains Focus on Operational Consistency and Greater Flexibility for Travellers
- Malaysia Airlines Maintains Focus on Operational Consistency and Greater Flexibility for Travellers
- Peach Blossoms Celebrates Three Massive Wins – Black Pearl Restaurant Guide 2026, Asia’s 50 Best Restaurants 2026 Extended List and Tatler Best 20 Restaurants in Singapore 2026
- Volvo Trucks announces global product launch – a range of new powertrains to reduce CO2 emissions and accelerate decarbonization
